QSI icon

Quantum-Si Incorporated

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 88.9%
Negative

Neutral
Seeking Alpha
16 days ago
Quantum-Si incorporated (QSI) Shareholder/Analyst Call Prepared Remarks Transcript
Quantum-Si incorporated (QSI) Shareholder/Analyst Call Prepared Remarks Transcript
Quantum-Si incorporated (QSI) Shareholder/Analyst Call Prepared Remarks Transcript
Neutral
Business Wire
17 days ago
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Neutral
MarketBeat
23 days ago
Quantum-Si Q1 Earnings Call Highlights
Quantum-Si NASDAQ: QSI reported first-quarter 2026 revenue of $258,000 and reiterated that the year will be a transition period focused on development and market preparation for its next-generation Proteus protein sequencing platform.
Quantum-Si Q1 Earnings Call Highlights
Neutral
Seeking Alpha
23 days ago
Quantum-Si incorporated (QSI) Q1 2026 Earnings Call Transcript
Quantum-Si incorporated (QSI) Q1 2026 Earnings Call Transcript
Quantum-Si incorporated (QSI) Q1 2026 Earnings Call Transcript
Negative
Zacks Investment Research
23 days ago
Quantum-Si Incorporated (QSI) Reports Q1 Loss, Misses Revenue Estimates
Quantum-Si Incorporated (QSI) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to a loss of $0.11 per share a year ago.
Quantum-Si Incorporated (QSI) Reports Q1 Loss, Misses Revenue Estimates
Neutral
Business Wire
24 days ago
Quantum-Si Reports First Quarter 2026 Financial Results and Highlights Proteus™ Development Milestones
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Reports First Quarter 2026 Financial Results and Highlights Proteus™ Development Milestones.
Quantum-Si Reports First Quarter 2026 Financial Results and Highlights Proteus™ Development Milestones
Neutral
Business Wire
1 month ago
Quantum-Si to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference.
Quantum-Si to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
Neutral
Business Wire
1 month ago
Quantum-Si Announces Successful Sequencing on Integrated Proteus™ Instruments
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Successful Sequencing on Integrated Proteus™ Instruments.
Quantum-Si Announces Successful Sequencing on Integrated Proteus™ Instruments
Neutral
Business Wire
1 month ago
Quantum-Si to Report First Quarter 2026 Financial Results on May 7, 2026
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Report First Quarter 2026 Financial Results on May 7, 2026.
Quantum-Si to Report First Quarter 2026 Financial Results on May 7, 2026
Neutral
Business Wire
1 month ago
Quantum-Si Announces Two Customer Posters to be Presented at the American Association of Cancer Research Annual Meeting
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Two Customer Posters to be Presented at the American Association of Cancer Research Annual Meeting.
Quantum-Si Announces Two Customer Posters to be Presented at the American Association of Cancer Research Annual Meeting